Increased prevalence of schizophrenia spectrum disorders in relatives of neuroleptic-nonresponsive schizophrenic patients

OBJECTIVE It is suggested that schizophrenic patients who respond to neuroleptic medication and those who do not might differ with respect to their pathogenesis. In particular, it has been proposed that genetic factors may contribute to treatment response and/or outcome. In order to test this hypothesis, we compared the pattern of familial aggregation of schizophrenia related disorders in schizophrenic patients who are either responders (R) or nonresponders (NR) to typical neuroleptics. METHOD R (n=36) or NR (n=35) patients to typical neuroleptics and healthy controls (n=63) were recruited. At least one key informant relative of each proband was interviewed blind as to the status of the proband using the Family Interview for Genetic Studies. Morbid risk for schizophrenia and cluster A personality disorders and family loading score for schizophrenia were examined in first- and second-degree relatives of these probands. RESULTS First-degree relatives of NR patients were at a significantly higher risk for schizophrenia (MR=8.84), compared, respectively, to relatives of controls (MR=1.52) or relatives of R patients (MR=2.45). The same pattern was observed in second-degree relatives. Family loading score for schizophrenia in first- and second-degree relatives was significantly higher in NR compared to R patients. CONCLUSIONS Schizophrenic patients who do not respond to typical neuroleptics may suffer from a more familial form of schizophrenia compared to patients who are responders.

[1]  J. Hirschowitz,et al.  Drug response patterns as a basis of nosology for the mood-incongruent psychoses (the schizophrenias) , 1988, Psychological Medicine.

[2]  D. Silber,et al.  Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study , 1981, Psychological Medicine.

[3]  C. Benkelfat,et al.  Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteers , 2002, Schizophrenia Research.

[4]  K. Davis,et al.  Familial schizophrenia and treatment response. , 1987, The American journal of psychiatry.

[5]  J. van Os,et al.  Does Familiality Predispose to both Emergence and Persistence of Psychosis? , 1996, British Journal of Psychiatry.

[6]  T. Cooper,et al.  Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia. , 1989, The American journal of psychiatry.

[7]  J. Fleiss,et al.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.

[8]  D. Rao,et al.  The transmission of schizophrenia under a multifactorial threshold model. , 1983, American journal of human genetics.

[9]  K. Kendler,et al.  Accuracies and inaccuracies of the family history method: a multivariate approach , 1996, Acta psychiatrica Scandinavica.

[10]  R. Liberman,et al.  At Issue: Defining Treatment Refractoriness in Schizophrenia , 1990 .

[11]  H. Nasrallah,et al.  Contemporary Issues in the Treatment of Schizophrenia , 1995 .

[12]  Delbert Miller,et al.  Handbook of research design and social measurement , 1993 .

[13]  G Honigfeld,et al.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. , 1988, Archives of general psychiatry.